on Tharimmune Inc. (NASDAQ:THAR)
Tharimmune Announces Participation in Upcoming Conferences
Tharimmune, Inc., a biotechnology company focused on inflammation and immunology, reveals its involvement in upcoming conferences this November. CEO Randy Milby will represent the company at the 2024 Spartan Capital Investor Conference on November 4 in New York City. Investors can register for one-on-one meetings with the management during the event.
Additionally, Chief Medical Advisor Dr. Nir Barak will present findings from the Phase 1 trial of TH104 at the AASLD Annual Conference, taking place from November 15-18 in San Diego. The presentation will address the relationship between TH104 pharmacokinetics and pruritus relief in cholestatic pruritus patients.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Tharimmune Inc. news